A Randomized Double Blind Placebo Controlled Clinical Trial Of N-Acetylcysteine Added To Risperidone For Treating Autistic Disorders
Notes for this study:
|Number of Subjects
||1-6, 7-12, 13-17
Eight weeks supplementation of NAC as adjuvant to risperidone therapy in children with autism was able to reduce irritability relative to placebo, but the other measured parameters (Lethargy and Social Withdrawal, Stereotypic Behavior, Hyperactivity, and Noncompliance) were not affected by treatment.